Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Cash flows from operating activities:
Net earnings	$ 82.8	$ 250.2
Non-cash items:
Depreciation and amortization expense	31.1	29.1
Stock-based compensation expense	6.8	6.1
Amortization of debt issuance costs	1.0	0.9
Gain on previously held equity interests from combination of business	0.0	(32.7)
Unrealized gain on equity securities measured at fair value	0.0	(163.0)
Amortization of acquisition-related inventory fair value step-up	0.8	0.0
Loss on equity investments	0.7	0.0
Gain on sale of property	(2.8)	0.0
Change in deferred income taxes	(5.7)	32.6
Change in accounts receivable and long-term financing receivables, net	42.1	33.7
Change in other operating assets and liabilities	(75.8)	(115.6)
Net cash provided by operating activities	81.0	41.3
Cash flows from investing activities:
Cash paid for acquisitions, net of cash received	0.0	(184.9)
Payments for additions to property, plant and equipment	(13.7)	(12.9)
Proceeds from sale of property	4.2	0.2
Cash paid for equity investments	(1.9)	(5.8)
Proceeds from sale of equity securities	20.4	0.0
Net cash provided by (used in) investing activities	9.0	(203.4)
Cash flows from financing activities:
Repayment of long-term debt	(65.0)	0.0
Net proceeds from short-term borrowings	3.9	0.4
Payments of common stock cash dividend	(3.9)	(4.0)
Purchases of treasury stock	(18.1)	(257.0)
Proceeds from stock option exercises	1.2	0.0
Other financing activities	(5.3)	(3.0)
Net cash used in financing activities	(87.2)	(263.6)
Effect of exchange rate changes on cash and cash equivalents	0.9	(1.8)
Net change in cash and cash equivalents	3.7	(427.5)
Beginning balance of cash and cash equivalents	204.5	572.6
Ending balance of cash and cash equivalents	$ 208.2	$ 145.1